These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 2902653)

  • 1. Platelet monoamine oxidase activity and tardive dyskinesia.
    Morgenstern H; Hafez HM; Glazer WM; Giller E; Zahner G
    Psychiatry Res; 1988 Aug; 25(2):163-71. PubMed ID: 2902653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet monoamine oxidase activity in the psychoses: relationship to symptoms and lithium response.
    Hitzemann RJ; Sautter F; Hitzemann B; Hirschowitz J; Garver DL
    Psychiatry Res; 1984 Mar; 11(3):211-21. PubMed ID: 6587414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of neuroleptic drugs on platelet monoamine oxidase in psychiatric patients.
    Meltzer HY; Duncavage MB; Jackman H; Arora RC; Tricou BJ; Young M
    Am J Psychiatry; 1982 Oct; 139(10):1242-8. PubMed ID: 6127035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of neuroleptics on platelet monoamine oxidase activity.
    Ho BT; Smith RC; Kralik P; Allen R; Schoolar J; Khan M; DeJohn C
    Biol Psychiatry; 1982 Aug; 17(8):885-95. PubMed ID: 6126230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A biochemical study of tardive dyskinesia in young male patients.
    Jeste DV; DeLisi LE; Zalcman S; Wise CD; Phelps BH; Rosenblatt JE; Potkin SG; Bridge TP; Wyatt RJ
    Psychiatry Res; 1981 Jun; 4(3):327-31. PubMed ID: 6115438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet monoamine oxidase activity and behavioral response to pharmacotherapy in psychiatric patients.
    Rosen AJ; Wirtshafter D; Pandey GN; Davis JM
    Psychiatry Res; 1982 Feb; 6(1):49-59. PubMed ID: 6120529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet monoamine oxidase response to lithium treatment in psychiatric patients.
    Huang LG; Bowden CL
    J Clin Psychopharmacol; 1984 Dec; 4(6):326-31. PubMed ID: 6512000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An inverse correlation between spontaneous eye-blink rate and platelet monoamine oxidase activity.
    Karson CN; Kleinman JE; Berman KF; Phelps BH; Wise CD; DeLisi LE; Jeste DV
    Br J Psychiatry; 1983 Jan; 142():43-6. PubMed ID: 6831128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet MAO activity and long-term outcome in schizophrenia and schizoaffective disorder.
    Malas KL; van Kammen DP
    Am J Psychiatry; 1983 Jun; 140(6):794-6. PubMed ID: 6846644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphocyte monoamine oxidase and plasma prolactin and growth hormone in tardive dyskinesia.
    Jeste DV; Neckers LM; Wagner RL; Wise CD; Staub RA; Rogol A; Potkin SG; Bridge TP; Wyatt RJ
    J Clin Psychiatry; 1981 Feb; 42(2):75-7. PubMed ID: 6109719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet monoamine oxidase in schizophrenia: a meta-analysis.
    Marcolin MA; Davis JM
    Schizophr Res; 1992 Sep; 7(3):249-67. PubMed ID: 1356426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzyme studies in tardive dyskinesia. II. Familial aspects.
    Delisi LE; Jeste DV; Phelps BH; Wyatt RJ
    J Clin Psychopharmacol; 1982 Oct; 2(5):315-7. PubMed ID: 7130433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Schizophrenia and platelet monoamine oxidase: research strategies.
    Buchsbaum MS; Coursey RD; Murphy DL
    Schizophr Bull; 1980; 6(2):375-84. PubMed ID: 6103578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of lithium on platelet monoamine oxidase activity in bipolar and schizoaffective disorders.
    Meltzer HY; Tueting P; Jackman H
    Br J Psychiatry; 1982 Feb; 140():192-8. PubMed ID: 7074305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet MAO activity in major psychoses.
    Gattaz WF
    Mod Probl Pharmacopsychiatry; 1983; 19():315-20. PubMed ID: 6135152
    [No Abstract]   [Full Text] [Related]  

  • 16. Platelet monoamine oxidase and plasma amine oxidase in psychiatric patients.
    Meltzer HY; Arora RC; Jackman H; Pscheidt G; Smith MD
    Schizophr Bull; 1980; 6(2):213-9. PubMed ID: 7375852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet monoamine-oxidase activity in schizophrenia. Relation to genetic load of the illness and treatment with antipsychotic drugs.
    Kemali D; Maj M; Ariano MG; Salvati A
    Encephale; 1985; 11(1):31-4. PubMed ID: 2859981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroleptic drug effect on platelet monoamine oxidase and plasma amine oxidase in schizophrenia.
    Baron M; Gruen R; Levitt M; Kane J
    Psychiatry Res; 1982 Oct; 7(2):179-87. PubMed ID: 6128754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoamine oxidase: studies of normal and psychiatric populations in a tropical environment.
    Sengupta N; Datta SC; Sengupta D
    Enzyme; 1981; 26(4):191-200. PubMed ID: 7250095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parents of high risk subjects defined by levels of monoamine oxidase activity.
    Puchall LB; Coursey RD; Buchsbaum MS; Murphy DL
    Schizophr Bull; 1980; 6(2):338-46. PubMed ID: 7375867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.